Please use this identifier to cite or link to this item:
Title: Editorial: Therapy-induced metastasis.
Austin Authors: Martin, Olga A;Anderson, Robin L 
Affiliation: Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
La Trobe University School of Cancer Medicine, Bundoora, VIC, Australia
Issue Date: Apr-2018
Date: 2018-07-03
Publication information: Clinical & experimental metastasis 2018; 35(4): 219-221
Abstract: The idea for this Special Issue originated from our recent review in Nature Reviews Clinical Oncology entitled "Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?" Martin et al. (Nat Rev Clin Oncol 14:32-44, 2017). While preparing this review, it became evident that an overwhelming number of preclinical and clinical papers were implicating the involvement of all the major and indispensable cancer treatment modalities in causing increased numbers of tumour cells in circulation (CTCs), and potentially increased risk of distant metastasis. This led to our decision to expand the topic by addressing some of the issues associated with therapy-induced tumour progression. Here, we present papers from ten research groups who give a comprehensive coverage of the biological processes and clinical procedures that can lead to enhanced metastasis and/or tumour recurrence. Our authors provide evidence that all the common therapies, including radiotherapy, chemotherapy, fine needle biopsies, surgical procedures and anaesthesia have the potential to contribute to tumour progression.
DOI: 10.1007/s10585-018-9914-x
ORCID: 0000-0002-6841-7422
Journal: Clinical & experimental metastasis
PubMed URL: 29971590
Type: Journal Article
Subjects: Cancer therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 7, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.